Collateral Medical: Financial Breakdown
Decoding financial health metrics of Collateral Medical
Total Revenue₹50.8 Cr+-24%Prev. FY
Total Expenses₹49.5 Cr+-23%Prev. FY
Profit After Tax₹1.3 Cr+-48%Prev. FY
Total Assets₹15.2 Cr+-4%Prev. FY
Net Profit Margin2.5%-33%Prev. FY
FAQs on Financials of Collateral Medical
Yes. In FY23, Collateral Medical reported a profit after tax of ₹1.3 Cr+, making it profitable.
Collateral Medical's revenue declined 23.2% year-on-year, from ₹66.1 Cr+ in FY22 to ₹50.8 Cr+ in FY23.
Collateral Medical's estimated EBITDA for FY23 was ₹2.2 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY23, Collateral Medical posted revenue of ₹50.8 Cr+ (down 23.2% YoY) and a profit after tax of ₹1.3 Cr+. Explore the full financials of Collateral Medical here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links